COVID-19 (SARS-CoV-2 infection) Infections and Infestations COVID-19 (SARS-CoV-2 infection)
Conditions
Interventions
We set up a study under the Human Tissue Authority licence at the Nottingham Tissue Bank (Licence holder:
Nottingham University Hospitals Trust, Licenced Tissue Bank (no. 11035)) to al
Sponsors
University of Nottingham
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Healthcare workers and their household contacts who have donated blood to the Nottingham Tissue Bank for use in COVID research 2. Capacity to consent 3. Speak English 4. Minimum age 16 years, no upper age limit
Exclusion criteria
Exclusion criteria: Declined to be contacted for future research
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Health-related quality of life (EQ-5D) at baseline and 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Development of COVID symptoms and antibodies during COVID pandemic, based on self-reporting and blood serology. This was measured during the first national lockdown, at the end of the first national lockdown, and in April 2021 2. Mood assessment measured using PHQ9 during the first national lockdown, at the end of the first national lockdown, and in April 2021 | — |
Countries
England, United Kingdom
Outcome results
None listed